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Conclusions As the management of compulsive behaviours is
complex, physician should better assess and recognize psycholog-
ical personality aspect, collecting patients’ complete history, also
testing them psychometrically, and paying more attention to an
eventual treatment (both psychological and pharmacological).
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Introduction One of the main risk factors for both HIV-infection
and syphilis is addictive behavior.
The objective of the study was to determine the impact of addic-
tions on the HIV and syphilis coinfection.
Method Sixty-five HIV-infected patients with syphilis were
examined by a clinical method.
Results The sample included 45 men (average age 32.09±9.83)
and 20 women (average age 31.7±5.97). All patients were char-
acterized by risky behavior. Seventy-one percent of men belonged
to the category of men who have sex with men (MSM). Eighty-five
percent of women had drug dependence (as compared to 61% for
menwho have sexwithwomen (MSW) and 19% forМSМ; P<0.05).
Women were more likely to have opiate dependence (P<0.001; as
compared to men). We revealed a high incidence of drug addiction
and alcoholismwith the prevalence of dependence onopioids (F11;
55.0%; 7.7%), polysubstance use (F19; 25.0%; 23.1%) and alcoholism
(F10; 50.0%; 61.25%) amongwomenandMSWrespectively (P<0.05
as compared toMSM). Only 50% ofwomen and 23% ofMSWwere in
remission. MSM regularly consumed stimulants and cannabinoids
without developing dependence.
Conclusions Injecting drug use is typical of women andMSWand
plays a leading role in the risk factors for HIV infection and syphilis.
Addictive behavior among MSM increases risky sexual behavior
and thus influences infection with HIV and syphilis.
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Introduction There are no data in literature on mental disorders
in HIV-infected patients with syphilis.
The objective of the studywas to determine the structure ofmental
disorders in HIV-infected patients with syphilis.
Method Sixty-five HIV-infected patients with syphilis were
examined by a clinical method.
Results The sample included 45 men (average age 32.09±9.83)
and 20 women (average age 31.7±5.97). We divided the sample
into three comparison groups (according to the importance of risk
factors): women, men who have sex with men (MSM), and men
who have sex with women (MSW).
Mental disorders were identified in most patients (83%). Opiate
dependence (F11, ICD-10) was established in 55% of women (7.7%
for MSW, 0% in MSM; P<0.001). The dependence on multiple
drug use (F19) was revealed with nearly the same frequency in
women (25.0%) and inMSW (23.1%); but far less frequently inMSM
(3.2%; P=0.047). The dependence on stimulants (F15) was found in
women (5.0%) and MSM (6.3%). The dependence on alcohol (F10)
was more common among MSW (61.5%) and women (50.0%) (9.4%
in MSM; P<0.001). 20% of women had Depressive episode (F32).
Adjustment disorders (F43) were found much more often in men
(43.8% for MSM; 38.5% for MSW; 10% for women; P=0.035). Per-
sonality disorders (F60) were found in all the groups.
Conclusions We revealed a high incidence of addictions among
women andMSW. Affective disorderswere represented by depres-
sive episode in women and adjustment disorders in men.
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Kratom (Mitragyna speciosa Korth) is a tropical tree, indigenous to
South East Asia. Historically, the plant is locally used as a stimulant,
a remedy in traditional medicine and in social context. Imported
to Western countries, Kratom is classified as a novel psychoactive
substance (NPS).
A systematic review of the literature on Mitragyna speciosa and
its main constituents was carried by our international multidisci-
plinary group. Results were qualitatively analysed in three main
areas of interest: in-vitro and preclinical data on pharmacology
and behavioral effects, laboratoristic techniques for identifi-
cation/characterization, epidemiological/toxicological reports on
humans.
At present, there is no systematic data on the prevalence of Kratom
use in all the native countries, but it seems to be considerable.
In South-East Asia, Kratom, even if banned, might be still con-
sidered a better option than other illicit drugs, an alternative
opioid treatment, a “natural” remedy with no real social stigma
attached to its consumption. In parallel, this ethno-drug seems
to be popular in Western countries, largely unregulated, easily
available on the Internet. Kratom pharmacology appears to be
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complex, with many alkaloids involved. The subjective effects in
humans are very peculiar and seem to be dose-dependent, rang-
ing from psycho-stimulant to sedative-narcotic. Available data
on Kratom suggest caution: this psychoactive plant could exhibit
a serious harmful potential. Kratom use seems to be associated
with drug dependency, development of withdrawal symptoms,
craving, serious adverse effects and life-threatening effects in a
multidrug-intoxicating scenario. On the other hand, its anxyiolitic,
antidepressant and analgesic properties deserve to be further stud-
ied.
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Prior studies have identified that individuals with comorbid sub-
stance use disorder and mental health disorder are at a greater risk
of benzodiazepine abuse compared to individuals that presentwith
mental health disorder without an accompanying substance use
disorder. These studies were conducted in predominantly white
populations, and little is known if the same associations are seen
in safety net health care networks. Also, the literature is mixed as
to whether or not psychiatrists’ prescription of benzodiazepines
places individuals at undue risk of benzodiazepine abuse.
We use 2013–2015 electronic health record data from a Boston
healthcare system. Patientswith benzodiazapene abusewere iden-
tified if they had received treatment under the ICD-9 code 304.1.
Benzodiazepine abuse was compared between patients with only
mental illness and patients with existing comorbid substance and
mental health disorder, in unadjusted comparisons and adjusted
regression models. Covariates in regression models were used to
identify subgroups at higher risk of benzodiazepine abuse.
Individuals with benzodiazepine abuse had higher rates of emer-
gency room and inpatient use than patients with other mental
health and/or substance use disorders. Those with comorbid
substance and mental disorder were significantly more likely
than individuals with mental or substance use disorder alone to
abuse benzodiazepines (P< .01). Among thosewith benzodiazepine
abuse, 93.3%werediagnosedwithamental illness, 75.6%werediag-
nosed with a substance use disorder (other than benzodiazepine),
and 64.4% had comorbid anxiety disorder and substance use dis-
order. These analyses suggest that patients with benzodiazepine
abuse have complex presentations and intensive service use.
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Introduction Opiates’s substitution therapy with methadone is
one of themain approaches used for drug-addicted patients, in Por-
tugal. The symptoms of withdrawal of methadone are the same as
the classical abstinence syndrome of opiates. In aminority of cases,
withdrawal of methadone has been related to the sudden appear-
ance of affective disorders and to a minor degree with psychotic
disorders.
Objectives The authors propose to do a brief literature review
about methadone and it is neuromodulation in central opiate-
dopamine system.
Aims The authors intend to report a clinical case illustrative of a
psychosis possible related tomethadone rapidwithdrawal, in a 39-
year-old woman without previous personal or familiar psychiatric
illness, except for the use of toxic substances.
Methods Literature review in scientific databases – Pubmed;
ScienceDirect. Case report of a patient admitted in Psychiatry
Department of Vila Nova de Gaia Hospital Center.
Results During admission, the patient’s condition consisted of
disorganized behavior, paranoid delusions and the presence of
auditory hallucinations. Was excluded other possible causes of
psychotic conditions and was admitted rapid methadone detox-
ification as the probable etiology. Neuroleptic treatment was
prescribed and psychotic symptoms improved progressively.
Conclusions In test animals, the behavioral effects of methadone
withdrawal have been related to its effects on cerebral amines,
especially on dopamine. A change in the neuromodulation of the
central opiate-dopamine systems, due to opiates’s substitution
therapy with methadone, could be related to psychotic pathogene-
sis. This work supports other authors that suggest that methadone
withdrawal can cause psychosis in individuals without previous
psychiatric conditions.
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Introduction Egypt is one of the most famous endemic areas for
hepatitis C virus. Drug use in Egypt is rising exponentially. Drug use
is always considered one of the main risk factors for HCV.
Objectives To assess the effect the route of drug use on the inci-
dence of HCV in the Egyptian population.
Aim To study the effects of opiates (tramadol andheroin) use and
the route of intake on the incidence of HCV infection among addicts
treated in Mamoura mental state hospital, Alexandria, Egypt.
Methods This is a cross-sectional study on drug dependence
patients visiting the out patient clinic for addiction in Elmamora
Hospital.
Subjects were divided into two groups.
Group I: Control group.
Twenty non-addict volunteers.
Group II: Cases groups (comprising 60 subjects)
This group will be divided into three sub-groups each contains 20
cases.
